Suppr超能文献

感染与生物膜形成:超越表面现象

infection and biofilm formation: going beyond the surface.

作者信息

Horton Mark V, Nett Jeniel E

机构信息

University of Wisconsin-Madison, Departments of Medicine and Medical Microbiology & Immunology, Wisconsin, United States of America.

出版信息

Curr Clin Microbiol Rep. 2020 Sep;7(3):51-56. doi: 10.1007/s40588-020-00143-7. Epub 2020 Jul 17.

Abstract

PURPOSE OF REVIEW

Emergent fungal pathogen is spreading in hospitals throughout the world and mortality rates for patients with invasive disease approach 60%. This species exhibits a heightened capacity to colonize skin, persist on hospital surfaces, rapidly disseminate in healthcare settings, and resist antifungal therapy.

RECENT FINDINGS

Current investigations show that produces biofilms, surface-adherent communities that resist antifungals and withstand desiccation. These biofilms form when is growing on skin or in conditions expected in the hospital environment and on implanted medical devices.

SUMMARY

Here we will highlight the topic of biofilm formation by . We illustrate how this process influences resistance to antimicrobials and promotes nosocomial transmission.

摘要

综述目的

新兴真菌病原体正在全球医院中传播,侵袭性疾病患者的死亡率接近60%。该菌种在皮肤定殖、在医院表面存活、在医疗机构中快速传播以及抵抗抗真菌治疗方面能力增强。

最新发现

当前研究表明,该菌可形成生物膜,即一种抵抗抗真菌药物并耐受干燥的表面附着群落。当该菌在皮肤或医院环境预期条件下以及植入式医疗设备上生长时,就会形成这些生物膜。

总结

在此,我们将重点介绍该菌形成生物膜的主题。我们阐述了这一过程如何影响对抗菌药物的耐药性并促进医院内传播。

相似文献

1
infection and biofilm formation: going beyond the surface.
Curr Clin Microbiol Rep. 2020 Sep;7(3):51-56. doi: 10.1007/s40588-020-00143-7. Epub 2020 Jul 17.
2
Metabolism and Growth Preferences in Physiologically Relevant Skin-like Conditions.
bioRxiv. 2025 May 19:2025.05.18.654780. doi: 10.1101/2025.05.18.654780.
5
Screening the CALIBR ReFRAME Library in Search for Inhibitors of Biofilm Formation.
Front Cell Infect Microbiol. 2020 Nov 25;10:597931. doi: 10.3389/fcimb.2020.597931. eCollection 2020.
6
Evaluation of a high-throughput assay for use on the cobas 5800/6800/8800 omni Utility Channel.
Microbiol Spectr. 2025 Jul;13(7):e0025425. doi: 10.1128/spectrum.00254-25. Epub 2025 May 16.
7
A clinical and molecular analysis of strains from Romania, 2022-2023.
Microbiol Spectr. 2025 Jul;13(7):e0280924. doi: 10.1128/spectrum.02809-24. Epub 2025 May 19.
8
Pathogenicity Evaluation on Fluconazole-Resistant Candida auris Clade V in Murine Model.
Mycopathologia. 2025 Jun 24;190(4):58. doi: 10.1007/s11046-025-00963-5.
9
Novel Keto-Alkyl-Pyridinium Antifungal Molecules Active in Models of Candida albicans Vascular Catheter Infection and Candida auris Skin Colonization.
Antimicrob Agents Chemother. 2023 May 17;67(5):e0008123. doi: 10.1128/aac.00081-23. Epub 2023 Apr 25.
10
Identification of Candida auris by PCR and assessment of biofilm formation by crystal violet assay.
Indian J Med Microbiol. 2023 Nov-Dec;46:100421. doi: 10.1016/j.ijmmb.2023.100421. Epub 2023 Jul 5.

引用本文的文献

2
Insights into Candida auris dispersal cells and their impact on antifungal resistance.
BMC Microbiol. 2025 May 29;25(1):342. doi: 10.1186/s12866-025-04055-8.
3
HIV protease inhibitors restore amphotericin B activity against Candida.
PLoS One. 2025 May 29;20(5):e0324080. doi: 10.1371/journal.pone.0324080. eCollection 2025.
4
Candida auris cells form giant lipid droplets to survive in harsh environments.
Commun Biol. 2025 May 22;8(1):783. doi: 10.1038/s42003-025-08204-7.
5
Antibiofilm activity of manogepix, ibrexafungerp, amphotericin B, rezafungin, and caspofungin against spp. biofilms of reference and clinical strains.
Antimicrob Agents Chemother. 2025 Jun 4;69(6):e0013725. doi: 10.1128/aac.00137-25. Epub 2025 May 15.
7
Potent anti-biofilm properties of plumbagin against fluconazole-resistant .
J Tradit Complement Med. 2024 Jun 10;15(2):140-146. doi: 10.1016/j.jtcme.2024.06.005. eCollection 2025 Mar.
8
The multidrug-resistant complex and phylogenetic related species: Insights into antifungal resistance mechanisms.
Curr Res Microb Sci. 2025 Jan 28;8:100354. doi: 10.1016/j.crmicr.2025.100354. eCollection 2025.
10

本文引用的文献

2
A clinical predictive model of candidaemia by Candida auris in previously colonized critically ill patients.
Clin Microbiol Infect. 2020 Nov;26(11):1507-1513. doi: 10.1016/j.cmi.2020.02.001. Epub 2020 Mar 10.
3
Candida auris Forms High-Burden Biofilms in Skin Niche Conditions and on Porcine Skin.
mSphere. 2020 Jan 22;5(1):e00910-19. doi: 10.1128/mSphere.00910-19.
4
Candida auris Isolates Resistant to Three Classes of Antifungal Medications - New York, 2019.
MMWR Morb Mortal Wkly Rep. 2020 Jan 10;69(1):6-9. doi: 10.15585/mmwr.mm6901a2.
6
Epidemiologic Shift in Candidemia Driven by Candida auris, South Africa, 2016-2017.
Emerg Infect Dis. 2019 Sep;25(9):1698-1707. doi: 10.3201/eid2509.190040.
7
: a comparison between planktonic and biofilm susceptibility to antifungal drugs.
J Med Microbiol. 2019 Sep;68(9):1353-1358. doi: 10.1099/jmm.0.001036. Epub 2019 Jul 4.
8
Successful treatment of a intra-articular infection.
Emerg Microbes Infect. 2019;8(1):866-868. doi: 10.1080/22221751.2019.1625287.
9
Farnesol increases the activity of echinocandins against Candida auris biofilms.
Med Mycol. 2020 Apr 1;58(3):404-407. doi: 10.1093/mmy/myz057.
10
Clinical spectrum and factors impacting outcome of Candida auris: a single center study from Pakistan.
BMC Infect Dis. 2019 May 6;19(1):384. doi: 10.1186/s12879-019-3999-y.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验